{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T18:06:17Z","timestamp":1769364377450,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.berh.2012.12.005","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T10:10:32Z","timestamp":1363428632000},"page":"57-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Thrombosis in vasculitis"],"prefix":"10.1016","volume":"27","author":[{"given":"Angelo L.","family":"Gaffo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.berh.2012.12.005_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and his triad: a question of attribution","volume":"143","author":"Bagot","year":"2008","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1016\/j.berh.2012.12.005_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.SMJ.0000105663.01648.25","article-title":"Virchow's triad revisited","volume":"97","author":"Brotman","year":"2004","journal-title":"Southern Medical Journal"},{"issue":"9","key":"10.1016\/j.berh.2012.12.005_bib3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2008.099051","article-title":"High frequency of venous thromboembolic events in Churg\u2013Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients","volume":"68","author":"Allenbach","year":"2009","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.12.005_bib5","doi-asserted-by":"crossref","unstructured":"Avina-Zubieta JA, Lacaille D, Sayre E, Kopec J, Choi H, editors. The risk of pulmonary embolism and deep vein thrombosis in giant cell arteritis: a population-based cohort study. Meeting of the American College of Rheumatology, October, 2012, Washington, D.C.","DOI":"10.1186\/ar3987"},{"issue":"8","key":"10.1016\/j.berh.2012.12.005_bib6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","article-title":"Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study","volume":"142","author":"Merkel","year":"2005","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.berh.2012.12.005_bib7","doi-asserted-by":"crossref","first-page":"e2011026","DOI":"10.4084\/mjhid.2011.026","article-title":"Behcet's syndrome and thrombosis","volume":"3","author":"Seyahi","year":"2011","journal-title":"Mediterranean Journal of Hematology and Infectious Diseases"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/rheumatology\/ken035","article-title":"Venous thromboembolism in ANCA-associated vasculitis\u2013incidence and risk factors","volume":"47","author":"Stassen","year":"2008","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2012.12.005_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/art.21704","article-title":"Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"55","author":"Weidner","year":"2006","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2012.12.005_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.berh.2012.12.005_bib11","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1538-7836.2011.04434.x","article-title":"Thromboembolic disease in systemic vasculitis is associated with enhanced microparticle-mediated thrombin generation","volume":"9","author":"Eleftheriou","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1016\/j.berh.2012.12.005_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1681\/ASN.2011030298","article-title":"Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles","volume":"23","author":"Hong","year":"2012","journal-title":"Journal of American Society of Nephrology"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.berh.2012.12.005_bib14","first-page":"2446","article-title":"The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event","volume":"34","author":"Sebastian","year":"2007","journal-title":"The Journal of Rheumatology"},{"issue":"11","key":"10.1016\/j.berh.2012.12.005_bib15","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/art.24957","article-title":"Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study","volume":"60","author":"Morgan","year":"2009","journal-title":"Arthritis & Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.24386","article-title":"Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis","volume":"60","author":"Faurschou","year":"2009","journal-title":"Arthritis & Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/acr.20433","article-title":"A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis","volume":"63","author":"Suppiah","year":"2011","journal-title":"Arthritis Care & Research (Hoboken)"},{"issue":"8","key":"10.1016\/j.berh.2012.12.005_bib18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10067-010-1430-6","article-title":"Behcet's disease: from east to west","volume":"29","author":"Davatchi","year":"2010","journal-title":"Clinical Rheumatology"},{"issue":"9","key":"10.1016\/j.berh.2012.12.005_bib19","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.27568","article-title":"Mortality in Behcet's disease","volume":"62","author":"Saadoun","year":"2010","journal-title":"Arthritis & Rheumatism"},{"issue":"3","key":"10.1016\/j.berh.2012.12.005_bib20","first-page":"402","article-title":"Vascular involvement in Behcet's disease","volume":"19","author":"Koc","year":"1992","journal-title":"The Journal of Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2012.12.005_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3349\/ymj.1997.38.6.423","article-title":"Clinical manifestations of Behcet's disease: an analysis of 2147 patients","volume":"38","author":"Gurler","year":"1997","journal-title":"Yonsei Medical Journal"},{"issue":"6","key":"10.1016\/j.berh.2012.12.005_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/rheumatology\/40.6.652","article-title":"Thrombosis in Behcet's disease: a retrospective survey from a single UK centre","volume":"40","author":"Ames","year":"2001","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.berh.2012.12.005_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-4632.2006.02832.x","article-title":"Vascular involvement in Behcet's disease: a retrospective analysis of 2319 cases","volume":"45","author":"Sarica-Kucukoglu","year":"2006","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1016\/j.berh.2012.12.005_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009740500255761","article-title":"Characteristics of vascular involvement in Behcet's disease","volume":"35","author":"Duzgun","year":"2006","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2012.12.005_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Annals of Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2012.12.005_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e3283410088","article-title":"Major vessel involvement in Behcet's disease: an update","volume":"23","author":"Calamia","year":"2011","journal-title":"Current Opinion in Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/art.24393","article-title":"Cerebral venous thrombosis in Behcet's disease","volume":"61","author":"Saadoun","year":"2009","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2012.12.005_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MD.0b013e318242ff37","article-title":"Pulmonary artery involvement and associated lung disease in Behcet disease: a series of 47 patients","volume":"91","author":"Seyahi","year":"2012","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.berh.2012.12.005_bib29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0046-8177(85)80250-1","article-title":"Pathologic features of Behcet's syndrome: a review of Japanese autopsy registry data","volume":"16","author":"Lakhanpal","year":"1985","journal-title":"Human Pathology"},{"issue":"2","key":"10.1016\/j.berh.2012.12.005_bib30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1378\/chest.118.2.479","article-title":"Intracardiac thrombus in Behcet's disease: a systematic review","volume":"118","author":"Mogulkoc","year":"2000","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.berh.2012.12.005_bib31","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s002680010282","article-title":"Comparison of coagulation parameters for healthy subjects and Behcet disease patients with and without vascular involvement","volume":"24","author":"Sengul","year":"2000","journal-title":"World Journal of Surgery"},{"issue":"11","key":"10.1016\/j.berh.2012.12.005_bib32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/35.11.1178","article-title":"Coagulation factor V gene mutation increases the risk of venous thrombosis in Behcet's disease","volume":"35","author":"Gul","year":"1996","journal-title":"British Journal of Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2012.12.005_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","article-title":"Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation","volume":"27","author":"Ahn","year":"2008","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.berh.2012.12.005_bib34","unstructured":"Kahraman O, Celebi-Onder S, Kamali S, editors. Long-term course of deep vein thrombosis in patients with Beh\u00e7et's disease. Meeting of the American College of Rheumatology, 2003, Orlando, FL."},{"issue":"8","key":"10.1016\/j.berh.2012.12.005_bib35","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/art.34450","article-title":"Immunosuppressants reduce venous thrombosis relapse in Behcet's disease","volume":"64","author":"Desbois","year":"2012","journal-title":"Arthritis & Rheumatism"},{"issue":"10","key":"10.1016\/j.berh.2012.12.005_bib36","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/ard.2008.087957","article-title":"Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease","volume":"68","author":"Hatemi","year":"2009","journal-title":"Annals of Rheumatic Diseases"},{"issue":"2","key":"10.1016\/j.berh.2012.12.005_bib37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/rheumatology\/37.2.208","article-title":"Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases","volume":"37","author":"Manna","year":"1998","journal-title":"British Journal of Rheumatology"},{"issue":"11","key":"10.1016\/j.berh.2012.12.005_bib38","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/rheumatology\/37.11.1251","article-title":"Risk factors for thrombotic events in giant cell arteritis and polymyalgia rheumatica","volume":"37","author":"Seriolo","year":"1998","journal-title":"British Journal of Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MD.0b013e3181af4518","article-title":"Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis","volume":"88","author":"Gonzalez-Gay","year":"2009","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.berh.2012.12.005_bib40","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arteritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis & Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib41","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis & Rheumatism"},{"issue":"3 Suppl. 49","key":"10.1016\/j.berh.2012.12.005_bib42","first-page":"S57","article-title":"Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis","volume":"26","author":"Narvaez","year":"2008","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MD.0b013e3181af70c1","article-title":"Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?","volume":"88","author":"Maksimowicz-McKinnon","year":"2009","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.berh.2012.12.005_bib44","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1253\/circj.CJ-09-0905","article-title":"Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis","volume":"74","author":"de Souza","year":"2010","journal-title":"Circulation Journal: Official Journal of the Japanese Circulation Society"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.avsg.2011.01.007","article-title":"Is thromboangiitis obliterans presentation influenced by cannabis addiction?","volume":"25","author":"Martin-Blondel","year":"2011","journal-title":"Annals of Vascular Surgery"},{"issue":"6","key":"10.1016\/j.berh.2012.12.005_bib46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/art.1780310620","article-title":"Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco","volume":"31","author":"Lie","year":"1988","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2012.12.005_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000441-199801000-00004","article-title":"Antiendothelial cell antibodies in thromboangiitis obliterans","volume":"315","author":"Eichhorn","year":"1998","journal-title":"The American Journal of the Medical Sciences"},{"issue":"3","key":"10.1016\/j.berh.2012.12.005_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0049-3848(00)00310-8","article-title":"The role of prothrombotic mutations in patients with Buerger's disease","volume":"100","author":"Avcu","year":"2000","journal-title":"Thrombosis Research"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1191\/1358863x02vm452oa","article-title":"Antiphospholipid antibodies in thromboangiitis obliterans","volume":"7","author":"Maslowski","year":"2002","journal-title":"Vascular Medicine"},{"issue":"11","key":"10.1016\/j.berh.2012.12.005_bib50","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-152-11-201006010-00026","article-title":"Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole","volume":"152","author":"Bradford","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/RHU.0b013e31820e6822","article-title":"Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine","volume":"17","author":"Ullrich","year":"2011","journal-title":"Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases"},{"issue":"12","key":"10.1016\/j.berh.2012.12.005_bib52","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/art.30590","article-title":"Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine","volume":"63","author":"Graf","year":"2011","journal-title":"Arthritis & Rheumatism"},{"issue":"7","key":"10.1016\/j.berh.2012.12.005_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D36G18R9CV","article-title":"Vasculopathy related to cocaine adulterated with levamisole: a review of the literature","volume":"18","author":"Pearson","year":"2012","journal-title":"Dermatology Online Journal"},{"issue":"11","key":"10.1016\/j.berh.2012.12.005_bib54","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/36.11.1210","article-title":"Polyarteritis nodosa and the antiphospholipid syndrome","volume":"36","author":"Dasgupta","year":"1997","journal-title":"British Journal of Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2012.12.005_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.rhu.0000135627.88021.d1","article-title":"Polyarteritis nodosa complicated by catastrophic antiphospholipid syndrome","volume":"10","author":"Han","year":"2004","journal-title":"Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases"},{"issue":"9812","key":"10.1016\/j.berh.2012.12.005_bib56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden","volume":"379","author":"Zoller","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2012.12.005_bib57","series-title":"Vasculitis","first-page":"373","article-title":"Kawasaki's disease","author":"Kato","year":"2008"},{"issue":"2","key":"10.1016\/j.berh.2012.12.005_bib58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1542\/peds.63.2.175","article-title":"Kawasaki disease: effect of treatment on coronary artery involvement","volume":"63","author":"Kato","year":"1979","journal-title":"Pediatrics"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T17:18:56Z","timestamp":1644599936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694213000041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1521694213000041"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2012.12.005","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis in vasculitis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2012.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}